Lidia Karabon - Concepedia

Author

Lidia Karabon

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy ORCID

Also Known As

Karabon L, Karabon Lidia, Karabon, Lidia, L Karabon, L. KARABON, L. Karabon, Lidia Karabon

107

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences Wroclaw Medical University University of Wrocław Medical University of Lublin

About

Lidia Karabon is an author at Ludwik Hirszfeld Institute of Immunology and Experimental Therapy specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	575
2	Public Health	5	5	230
3	Blood Transplantation	2	2	107
4	Social Sciences	1	1	34
5	Allergy	1	1	17

Lidia Karabon

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation Dorota Frydecka, Błażej Misiak, Edyta Pawlak, European Archives of Psychiatry and Clinical Neuroscience	2014	131
IL-6 and IL-10 Promoter Gene Polymorphisms of Patients and Donors of Allogeneic Sibling Hematopoietic Stem Cell Transplants Associate With the Risk of Acute Graft-Versus-Host Disease Lidia Karabon, Barbara Wysoczańska, Katarzyna Bogunia‐Kubik, Human Immunology TransplantationAutoimmune DiseaseMarrow TransplantationStem Cell TransplantationImmunology	2005	69
Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population Edyta Pawlak, Lidia Karabon, Iwona Włodarska−Polińska, Human Immunology Cervical Cancer ManagementCervical CancerCervical HealthGenetic EpidemiologyImmunology	2009	63
Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms Jacek Daroszewski, Edyta Pawlak, Lidia Karabon, European Journal of Endocrinology	2009	61
IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma Grzegorz Mazur, Katarzyna Bogunia‐Kubik, Tomasz Wróbel, Immunology Letters Hematological MalignancyHematologyGenetic EpidemiologyImmunologyPathology	2004	59
Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population Katarzyna Suwalska, Edyta Pawlak, Lidia Karabon, Human Immunology	2008	59
Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia Dorota Frydecka, Błażej Misiak, Jan Aleksander Beszłej, Molecular Biology Reports	2013	48
CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer Lidia Karabon, Edyta Pawlak, Anna Tomkiewicz, Human Immunology OncologyNon-small-cell Lung CancerMedicineImmunologyPathology	2011	48
The <i>CTLA‐4</i> gene polymorphisms are associated with CTLA‐4 protein expression levels in multiple sclerosis patients and with susceptibility to disease Lidia Karabon, Agata Kosmaczewska, Małgorzata Bilińska, Immunology Jo31g AlleleGeneticsImmunodeficienciesGenetic EpidemiologyImmunology	2009	48
IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity Ilona Kryczek, Marian Gryboś, Lidia Karabon, British Journal of Cancer	2000	42

Page 1